Author:
Brandt Lasse,Heinz Andreas,Henssler Jonathan
Publisher
Springer International Publishing
Reference120 articles.
1. Adli M, Baethge C, Heinz A, Langlitz N, Bauer M. Is dose escalation of antidepressants a rational strategy after a medium–dose treatment has failed? Eur Arch Psychiatry Clin Neurosci. 2005;255(6):387–400.
2. Ainsworth K, Smith SE, Zetterström TSC, Pei Q, Franklin M, Sharp T. Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat. Psychopharmacology. 1998;140(4):470–7.
3. Allgulander C, Florea I, Huusom A. Prevention of relapse in generalized anxiety disorder by escitalopram treatment. Int J Neuropsychopharmacol. 2006;9(5):495–505.
4. American Psychiatric Association (APA). Practice guideline for the treatment of patients with major depressive disorder. In: American Psychiatric Association, editor. Practice guidelines for the treatment of people with psychiatric disorders. Washington, DC: American Psychiatric Association (APA). Guideline Central; 2000. p. 413–96.
5. Arroll B. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med. 2005;3(5):449–56.